KPTI -23% on day; Karyopharm Therapeutics Slides on Disclosure of Cash-Retention Program for Executives (out Friday) Link To Story from MARK
KPTI -23% on day; Karyopharm Therapeutics Slides on Disclosure of Cash-Retention Program for Executives (out Friday) Link To Story from MARKETWATCH.com
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.